Ionis Pharmaceuticals Inc
IONS· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $117.75M | $112.27M | $38.47M | $120.43M |
| Net Income | -$40.36M | -$3.09M | -$56.86M | $35.65M |
| EPS Diluted | -$0.29 |
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR
| -$0.02 |
| -$0.47 |
| $0.29 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.